274 related articles for article (PubMed ID: 7068280)
1. Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c mice.
Parmiani G; Sensi ML; Carbone G; Colombo M; Pierotti M; Ballinari D; Hilgers J; Hilkens J
Int J Cancer; 1982 Mar; 29(3):323-32. PubMed ID: 7068280
[TBL] [Abstract][Full Text] [Related]
2. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
Sensi ML; Parenza M; Parmiani G
J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
[TBL] [Abstract][Full Text] [Related]
3. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
4. Passive adoptive immunotherapy of low-immunogenic BALB/c lymphoma by syngeneic alloimmune T lymphocytes.
Colombo MP; Arioli I; Parmiani G
Int J Cancer; 1984 Dec; 34(6):807-13. PubMed ID: 6334656
[TBL] [Abstract][Full Text] [Related]
5. Expression of alien minor histocompatibility antigens distinct from tumor-specific transplantation antigen on a murine fibrosarcoma.
Parmiani G; Colombo M; Ballinari D
Int J Cancer; 1980 Oct; 26(4):461-5. PubMed ID: 7251224
[TBL] [Abstract][Full Text] [Related]
6. Importance of non-H-2 genes in the control of the in vivo growth of the virus induced lymphoma YC8.
Colombo MP; Parmiani G
J Immunogenet; 1981 Oct; 8(5):405-13. PubMed ID: 6795282
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the cellular immune response to and adoptive immunotherapy of a BALB/c lymphoma that cross-reacts with normal DBA/2 cells.
Sensi M; Grazioli L; Parmiani G
Cancer Immunol Immunother; 1986; 21(3):199-204. PubMed ID: 2938737
[TBL] [Abstract][Full Text] [Related]
8. Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I. In vivo studies.
Parmiani G; Invernizzi G
Int J Cancer; 1975 Nov; 16(5):756-67. PubMed ID: 52628
[TBL] [Abstract][Full Text] [Related]
9. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP
Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527
[TBL] [Abstract][Full Text] [Related]
10. Adoptive therapy of established syngeneic leukemia by cells primarily sensitized in vitro.
Cheever MA; Greenberg PD; Fefer A
Cancer Res; 1981 Jul; 41(7):2658-63. PubMed ID: 7018668
[TBL] [Abstract][Full Text] [Related]
11. DBA/2-like minor histocompatibility antigens on a BALB/c lymphoma. A BALB/c anti-DBA/2 serum which lyses the tumor and blocks BALB/c anti-tumor and anti-DBA/2 effectors.
Ballinari D; Grazioli L; Sensi ML; Borrello MG; Parmiani G
Int J Cancer; 1985 Nov; 36(5):617-22. PubMed ID: 3877002
[TBL] [Abstract][Full Text] [Related]
12. Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: characterization of the effector population and evidence for the role of the host's non-T cells.
Colombo MP; Parenza M; Parmiani G
Cancer Immunol Immunother; 1985; 20(3):198-204. PubMed ID: 3851699
[TBL] [Abstract][Full Text] [Related]
13. Immunological characteristics of leukemia and lymphoma in allogeneic cell immunity: growth of syngeneic tumors in rats immunized with allogeneic cells.
Hosokawa M; Yamashita T; Gotohda E; Takeichi N; Kodama T; Kobayashi H
Int J Cancer; 1978 Jul; 22(1):91-7. PubMed ID: 681026
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
15. Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice.
Fioretti MC; Libarati M; Bonmassar E; Cudkowicz G
Cancer Res; 1975 Jan; 35(1):30-6. PubMed ID: 1089042
[TBL] [Abstract][Full Text] [Related]
16. Protection against syngeneic tumor grafts induced by inoculation with normal allogeneic tissues.
Bear RH; Roholt OA; Pressman D
Immunol Commun; 1977; 6(6):547-58. PubMed ID: 342393
[TBL] [Abstract][Full Text] [Related]
17. Modification of the anti-tumour immune response by suppressor gene products of lymphoid cells.
De Giorgi L; Matossian-Rogers A; Festenstein H
Immunology; 1979 Apr; 36(4):711-8. PubMed ID: 108205
[TBL] [Abstract][Full Text] [Related]
18. Syngeneic and allogeneic mouse lymphoma antisera: specificity, reaction with fetal antigen and protective capacity.
Prager MD; Granatek CH; Ludden CM
Isr J Med Sci; 1976; 12(4-5):325-33. PubMed ID: 939692
[TBL] [Abstract][Full Text] [Related]
19. Multiple foreign non-H-2 determinants on the surface of a chemically-induced murine sarcoma.
Invernizzi G; Carbone G; Meschini A; Parmiani G
J Immunogenet; 1977 Apr; 4(2):97-106. PubMed ID: 874338
[TBL] [Abstract][Full Text] [Related]
20. Growth of transplantable melanoma and leukaemia and prevention of virus-induced leukaemia in long lived radiation chimeras constructed with unmanipulated bone marrow.
Pierpaoli W
Clin Exp Immunol; 1985 Jan; 59(1):210-6. PubMed ID: 3882284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
